News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Policy
AstraZeneca PLC Fails to Win FDA Approval for Axanum
June 1, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Bloomberg -- AstraZeneca Plc, the U.K.’s second- largest drugmaker, failed to get approval from U.S. regulators for an experimental treatment to prevent ulcers.
Twitter
LinkedIn
Facebook
Email
Print
Regulatory
AstraZeneca Pharmaceuticals LP
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Drug pricing
Trump’s Drug Pricing Order ‘More Bark Than Bite’
May 12, 2025
·
5 min read
·
Annalee Armstrong
Drug pricing
White House Unwraps Massive Drug Pricing Policy, Touching All Corners of Pharma
May 12, 2025
·
6 min read
·
Annalee Armstrong
Vaccines
FDA, EU Flag Safety Issues With Valneva’s Chikungunya Vaccine
May 12, 2025
·
2 min read
·
Tristan Manalac
Artificial intelligence
Amid Layoffs, Delays, FDA Turns to AI for Speedy Reviews
May 9, 2025
·
2 min read
·
Tristan Manalac
